Cargando…
Intratumoral SIRPα-deficient macrophages activate tumor antigen-specific cytotoxic T cells under radiotherapy
Radiotherapy (RT)-induced tumoricidal immunity is severely limited when tumors are well-established. Here, we report that depleting SIRPα on intratumoral macrophages augments efficacy of RT to eliminate otherwise large, treatment-resistant colorectal (MC38) and pancreatic (Pan02 and KPC) tumors, ind...
Autores principales: | Bian, Zhen, Shi, Lei, Kidder, Koby, Zen, Ke, Garnett-Benson, Charlie, Liu, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163884/ https://www.ncbi.nlm.nih.gov/pubmed/34050181 http://dx.doi.org/10.1038/s41467-021-23442-z |
Ejemplares similares
-
SIRPα expression delineates subsets of intratumoral monocyte/macrophages with different functional and prognostic impact in follicular lymphoma
por: Chen, Ya-Ping, et al.
Publicado: (2019) -
SIRPα blockade improves the antitumor immunity of radiotherapy in colorectal cancer
por: Ji, Kai, et al.
Publicado: (2023) -
Anticancer efficacy of monotherapy with antibodies to SIRPα/SIRPβ1 mediated by induction of antitumorigenic macrophages
por: Sakamoto, Mariko, et al.
Publicado: (2021) -
Leishmania Infection-Induced Proteolytic Processing of SIRPα in Macrophages
por: Hirai, Hana, et al.
Publicado: (2023) -
Loss of microglial SIRPα promotes synaptic pruning in preclinical models of neurodegeneration
por: Ding, Xin, et al.
Publicado: (2021)